5//SEC Filing
Bollon Arthur 5
Accession 0001140361-09-004334
CIK 0001301348other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:41 PM ET
Size
9.7 KB
Accession
0001140361-09-004334
Insider Transaction Report
Form 5
HEMOBIOTECH, INC.HMBT.OB
Bollon Arthur
DirectorChief Executive Officer
Transactions
- Award
Stock Option
2008-04-23+100,000→ 100,000 totalExercise: $1.25Exp: 2013-04-23→ Common Stock (100,000 underlying) - Other
Common Stock
2003-04-08$0.00/sh−117,000$234→ 1,599,059 total - Other
Common Stock
2008-11-02$1.25/sh−52,778$65,973→ 1,599,059 total
Footnotes (4)
- [F1]Shares originally reported as beneficially owned by reporting person on Form 3. Reporting person disclaims beneficial ownership and has no pecuniary interest in these 117,000 Shares.
- [F2]Form 4 filed on November 2, 2008 inadvertently listed vested options as Common Shares.
- [F3]As reported on Form 4 November 2, 2008 1,768,837 Shares (117,000)see above ( 52,778)see above 1,599,059see above
- [F4]Options vest 50% immediately upon issuance and the remainder vest over 36 monthly installments.
Documents
Issuer
HEMOBIOTECH, INC.
CIK 0001301348
Entity typeother
Related Parties
1- filerCIK 0001329091
Filing Metadata
- Form type
- 5
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:41 PM ET
- Size
- 9.7 KB